JETEMA, Co., Ltd. (KOSDAQ:216080)
South Korea · Delayed Price · Currency is KRW 6,080.00
-40.00 (-0.65%)
Oct 10, 2025, 3:30 PM KST
JETEMA, Market Cap
JETEMA, has a market cap or net worth of 218.02 billion as of October 10, 2025. Its market cap has decreased by -24.55% in one year.
Market Cap
218.02B
Enterprise Value
314.35B
Revenue
70.39B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,080.00
Market Cap Chart
Since November 14, 2019, JETEMA,'s market cap has increased from 129.11B to 218.02B, an increase of 68.87%. That is a compound annual growth rate of 9.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 218.02B | -21.39% |
| Dec 30, 2024 | 277.33B | -0.13% |
| Dec 28, 2023 | 277.70B | 19.01% |
| Dec 29, 2022 | 233.35B | -35.77% |
| Dec 30, 2021 | 363.31B | -9.68% |
| Dec 30, 2020 | 402.27B | 139.94% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |